Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vineeth Varanasi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Loss of the death receptor CD95 (Fas) expression by dendritic cells protects from a chronic viral infectionVineeth Varanasi, Aly Azeem Khan, Alexander V Chervonsky
Diabetes|July 10, 2012
Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cellsVineeth Varanasi, Lia Avanesyan, Desiree M Schumann, et al.
Scientific Reports|April 6, 2017
Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinaseShalini Tanwar, Atika Dhar, Vineeth Varanasi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 studyVadrevu Krishna Mohan, Vineeth Varanasi, Anit Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2026
B cells enable autoreactive T cells to avoid suppressionMatthew Funsten, Renee de Pooter, Vineeth Varanasi, et al.
The Journal of Infectious Diseases|September 14, 2010
A superantigen interacts with leishmanial infection in antigen-presenting cells to regulate cytokine commitment of responding CD4 T cellsVineeth Varanasi, Hamid Mattoo, Nitin C Tupperwar, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2024
Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticariaHidetoshi Takahashi, Atsushi Fukunaga, Koremasa Hayama, et al.
Nature Medicine|February 28, 2012
NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesAndrew Zloza, Frederick J Kohlhapp, Gretchen E Lyons, et al.
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Loss of the death receptor CD95 (Fas) expression by dendritic cells protects from a chronic viral infectionVineeth Varanasi, Aly Azeem Khan, Alexander V Chervonsky
Diabetes|July 10, 2012
Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cellsVineeth Varanasi, Lia Avanesyan, Desiree M Schumann, et al.
Scientific Reports|April 6, 2017
Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinaseShalini Tanwar, Atika Dhar, Vineeth Varanasi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 studyVadrevu Krishna Mohan, Vineeth Varanasi, Anit Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2026
B cells enable autoreactive T cells to avoid suppressionMatthew Funsten, Renee de Pooter, Vineeth Varanasi, et al.
The Journal of Infectious Diseases|September 14, 2010
A superantigen interacts with leishmanial infection in antigen-presenting cells to regulate cytokine commitment of responding CD4 T cellsVineeth Varanasi, Hamid Mattoo, Nitin C Tupperwar, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2024
Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticariaHidetoshi Takahashi, Atsushi Fukunaga, Koremasa Hayama, et al.
Nature Medicine|February 28, 2012
NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesAndrew Zloza, Frederick J Kohlhapp, Gretchen E Lyons, et al.
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Pageof 1